1-3 of 3
Stefano Fanti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma

Elena Zamagni, Cristina Nanni, Katia Mancuso, Paola Tacchetti, Annalisa Pezzi, Lucia Pantani, Beatrice Zannetti, Ilaria Rambaldi, Annamaria Brioli, Serena Rocchi, Carolina Terragna, Marina Martello, Giulia Marzocchi, Enrica Borsi, Ilaria Rizzello, Stefano Fanti, Michele Cavo
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (19): 4384–4390.
https://doi.org/10.1158/1078-0432.CCR-15-0396
Published: 30 September 2015
View article titled, PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma
Open the PDF for PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy

Roberto Tonelli, Alan McIntyre, Consuelo Camerin, Zoë S. Walters, Korinne Di Leo, Joanna Selfe, Stefania Purgato, Edoardo Missiaglia, Andrea Tortori, Jane Renshaw, Annalisa Astolfi, Kathryn R. Taylor, Salvatore Serravalle, Ryan Bishop, Cristina Nanni, Linda J. Valentijn, Andrea Faccini, Ivo Leuschner, Serena Formica, Jorge S. Reis-Filho, Valentina Ambrosini, Khin Thway, Monica Franzoni, Brenda Summersgill, Rosangela Marchelli, Patrizia Hrelia, Giorgio Cantelli-Forti, Stefano Fanti, Roberto Corradini, Andrea Pession, Janet Shipley
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (3): 796–807.
https://doi.org/10.1158/1078-0432.CCR-11-1981
Published: 31 January 2012
View article titled, Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy
Open the PDF for Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy in another window
Includes: Supplementary data
Journal Articles

Phase II Trial of Short-Course R-Chop Followed by 90Y-Ibritumomab Tiuxetan in Previously Untreated High-Risk Elderly Diffuse Large B-Cell Lymphoma Patients

Pier Luigi Zinzani, Giuseppe Rossi, Silvia Franceschetti, Barbara Botto, Alice Di Rocco, Maria Giuseppina Cabras, Maria Concetta Petti, Vittorio Stefoni, Alessandro Broccoli, Stefano Fanti, Cinzia Pellegrini, Gian Carlo Montini, Letizia Gandolfi, Enrico Derenzini, Lisa Argnani, Mariapaola Fina, Alessandra Tucci, Chiara Bottelli, Stefano Pileri, Michele Baccarani
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (15): 3998–4004.
https://doi.org/10.1158/1078-0432.CCR-10-0162
Published: 28 July 2010
View article titled, Phase II Trial of Short-Course R-Chop Followed by <sup>90</sup>Y-Ibritumomab Tiuxetan in Previously Untreated High-Risk Elderly Diffuse Large B-Cell Lymphoma Patients
Open the PDF for Phase II Trial of Short-Course R-Chop Followed by <sup>90</sup>Y-Ibritumomab Tiuxetan in Previously Untreated High-Risk Elderly Diffuse Large B-Cell Lymphoma Patients in another window